医学
焦虑
荟萃分析
随机对照试验
物理疗法
社会心理的
奇纳
心肌梗塞
心理信息
梅德林
心理干预
萧条(经济学)
内科学
精神科
宏观经济学
政治学
经济
法学
作者
Wendan Shi,Gabriela L. M. Ghisi,Ling Zhang,Karice Hyun,Maureen Pakosh,Robyn Gallagher
标识
DOI:10.1093/eurjcn/zvac001
摘要
Abstract Background Patient education is a cardiac rehabilitation core component and is associated with improvements in self-management of patients with coronary heart disease (CHD). However, the efficacy of such interventions on psychosocial outcomes and relative impact of duration is less clear. Objectives This study aimed to assess the efficacy of patient education for secondary prevention related to behaviour change and risk factor modification on psychological outcomes in CHD patients. Design A systematic review and meta-analysis. Data sources PsycINFO, CINAHL, Embase, EmCare, MEDLINE, PubMed, and the Cochrane Central Register of Controlled Trials were searched from inception to February 2021. Eligibility criteria for study selection Randomized controlled trials (RCTs) evaluating patient education in CHD patients, or following myocardial infarction, or revascularization compared with usual care were identified. Outcomes included depression and anxiety at <6 and 6–12 months of follow-up. Results A total of 39 RCTs and 8748 participants were included. Patient education significantly improved participants’ depressive symptoms at <6 (SMD −0.82) and 6–12 months (SMD −0.38) of follow-up and anxiety level at <6 (SMD −0.90), and 6–12 months (SMD −0.32) of follow-up. Patient education also reduced the risk for having clinical depression by 35% and anxiety by 60%. Longer patient education of ≥3 months, resulted in more improvement in depressive symptoms at 6–12 months (coefficient −0.210) compared to shorter duration. Conclusions Patient education for secondary prevention reduces anxiety and depressive symptoms in CHD patients. Regardless of intensity, longer patient education improves depression more than short duration. More information is needed on the relative impact of other intervention components. Data registration PROSPERO (CRD42020200504).
科研通智能强力驱动
Strongly Powered by AbleSci AI